Source directory

Source Directory

Abedon, S. T., Kuhl, S. J., Blasdel, B. G., & Kutter, E. M. (2011). Phage treatment of human infections. Bacteriophage, 1(2), 66–85. http://doi.org/10.4161/bact.1.2.15845

Ackerman, J. (2012). The ultimate social network. Scientific American, 306(6), 36–43. http://doi.org/10.1038/scientificamerican0612-36

Ai, D., Huang, R., Wen, J., Li, C., Zhu, J., & Xia, L. C. (2017). Integrated metagenomic data analysis demonstrates that a loss of diversity in oral microbiota is associated with periodontitis. BMC Genomics, 18(S1), 1041. http://doi.org/10.1186/s12864-016-3254-5

Alekseyenko, A. V, Perez-Perez, G. I., De Souza, A., Strober, B., Gao, Z., Bihan, M., … Blaser, M. J. (2013). Community differentiation of the cutaneous microbiota in psoriasis. Microbiome, 1(1), 31. http://doi.org/10.1186/2049-2618-1-31

Andersson, D. I., Hughes, D., & Kubicek-Sutherland, J. Z. (2016). Mechanisms and consequences of bacterial resistance to antimicrobial peptides. Drug Resistance Updates, 26, 43–57. http://doi.org/10.1016/j.drup.2016.04.002

Bahar, A. A., & Ren, D. (2013). Antimicrobial peptides. Pharmaceuticals, 6(12), 1543–1575. http://doi.org/10.3390/ph6121543

Barbut, F., & Meynard, J. L. (2002). Managing antibiotic associated diarrhoea. BMJ (Clinical Research Ed.), 324(7350), 1345–6. http://doi.org/10.1136/bmj.324.7350.1345

Blaser, Martin J., Missing Microbes: How the Overuse of Antibiotics Is Fueling Our Modern Plagues, Henry Holt Verlag, New York, 2014

Blekhman, R., Goodrich, J. K., Huang, K., Sun, Q., Bukowski, R., Bell, J. T., … Clark, A. G. (2015). Host genetic variation impacts microbiome composition across human body sites. Genome Biology, 16(1), 191. http://doi.org/10.1186/s13059-015-0759-1

Bokulich, N. A., Subramanian, S., Faith, J. J., Gevers, D., Gordon, I., Knight, R., … Manuscript, A. (2013). Quality-filtering vastly improves diversity estimates from Illumina amplicon sequencing. NIH Public Access. Genomics, 10(1), 151–170. http://doi.org/10.1146/annurev-genom-090711-163814.

Briers, Y., & Lavigne, R. (2015). Breaking barriers: expansion of the use of endolysins as novel antibacterials against Gram-negative bacteria. Future Microbiology, 10(3), 377–390. https://doi.org/10.2217/fmb.15.8

Briers, Y., Walmagh, M., Grymonprez, B., Biebl, M., Pirnay, J. P., Defraine, V., … Lavigne, R. (2014). Art-175 is a highly efficient antibacterial against multidrug-resistant strains and persisters of Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy, 58(7), 3774–3784. https://doi.org/10.1128/AAC.02668-14

Briers, Y., Walmagh, M., Puyenbroeck, V. Van, Cornelissen, A., Cenens, W., Aertsen, A., & Oliveira, H. (2014). Engineered Endolysin Based “ Artilysins ” To Combat Multidrug Resistant GramNegative pathogens. mBio, 5(4), 1–10. https://doi.org/10.1128/mBio.01379-14.Editor

Chen, Y., & Tsao, H. (2013). The skin microbiome: current perspectives and future challenges. Journal of the American Academy of Dermatology, 69(1), 143–155. http://doi.org/10.1016/j.jaad.2013.01.016.The

Christina, S., Ltg, M., Spies, S., Werle, K., Alice, B., Ltg, K., … Rabe, G. (2016). Was unsere Bakterien über uns verraten. Spektrum der Wissenschaft

Clemente, J. C., Pehrsson, E. C., Blaser, M. J., Sandhu, K., Gao, Z., Wang, B., … Dominguez-Bello, M. G. (2015). The microbiome of uncontacted Amerindians. Science Advances, 1(3), e1500183–e1500183. http://doi.org/10.1126/sciadv.1500183

Cooper, A. J., Weyrich, L. S., Dixit, S., & Farrer, A. G. (2015). The skin microbiome: Associations between altered microbial communities and disease. Australasian Journal of Dermatology, 56(4), 268–274. http://doi.org/10.1111/ajd.12253

Defraine, V., Schuermans, J., Grymonprez, B., Govers, S. K., Aertsen, A., Fauvart, M., … Briers, Y. (2016). Efficacy of artilysin art-175 against resistant and persistent acinetobacter baumannii. Antimicrobial Agents and Chemotherapy, 60(6), 3480–3488. https://doi.org/10.1128/AAC.00285-16

Dietert, R. R., & Silbergeld, E. K. (2015). Biomarkers for the 21st century: Listening to the microbiome. Toxicological Sciences, 144(2), 208–216. http://doi.org/10.1093/toxsci/kfv013

Dye, C. (2014). After 2015: infectious diseases in a new era of health and development. Philos Trans R Soc Lond B Biol Sci, 369(1645), 20130426. http://doi.org/10.1098/rstb.2013.0426

Gaskins, H. R. (1999). Developmental Microbial Ecology of the Neonata GIT. The American Journal of Clinical Nutrition, 69, 1035S–1045S.

Gerstmans, H., Rodriguez-Rubio, L., Lavigne, R., & Briers, Y. (2016). From endolysins to Artilysin(R)s: novel enzyme-based approaches to kill drug-resistant bacteria. Biochemical Society Transactions, 44(1), 123–128. https://doi.org/10.1042/BST20150192

Grice, Elizabeth A. (Genetics and Molecular Biology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, 20892–4442, U. ., & Segre, J. A. (2013). The skin microbiome. Nat Rev Microbiol, 9(4), 244–253. http://doi.org/10.1038/nrmicro2537.The

Huang, B., Fettweis, J. M., Brooks, J. P., Jefferson, K. K., & Buck, G. A. (2014). The changing landscape of the vaginal microbiome. Clinics in Laboratory Medicine, 34(4), 747–761. http://doi.org/10.1016/j.cll.2014.08.006

Hug, L. A., Baker, B. J., Anantharaman, K., Brown, C. T., Probst, A. J., Castelle, C. J., … Banfield, J. F. (2016). A new view of the tree of life. Nature Microbiology, 1(5), 1–6. http://doi.org/10.1038/nmicrobiol.2016.48

Indrio, F., Martini, S., Francavilla, R., Corvaglia, L., Cristofori, F., Mastrolia, S. A., … Loverro, G. (2017). Epigenetic Matters: The Link between Early Nutrition, Microbiome, and Long-term Health Development. Frontiers in Pediatrics, 5(August), 1–14. http://doi.org/10.3389/fped.2017.00178

Kashani, H. H., Schmelcher, M., Sabzalipoor, H., Hosseini, E. S., & Moniri, R. (2017). Recombinant Endolysins as Potential Therapeutics against Antibiotic-Resistant Staphylococcus aureus : Current Status of Research and Novel Delivery Strategies. https://doi.org/10.1128/CMR.00071-17

Khanna, S., & Tosh, P. K. (2014). A clinician’s primer on the role of the microbiome in human health and disease. Mayo Clinic Proceedings, 89(1), 107–114. http://doi.org/10.1016/j.mayocp.2013.10.011

Kong, H. H. (2015). Temporal shifts in the skin microbiome associated with disease flare and treatment in children with atopic dermatitis. Genome Research, 850–859. http://doi.org/10.1101/gr.131029.111

Kong, H. H., & Segre, J. A. (2012). Skin microbiome: looking back to move forward. HHS Public Access, 132(3), 933–939. http://doi.org/10.1038/jid.2011.417.

Lederberg J, McCray AT ; Genealogical Treasury of Words. Scientist. 2001;15(7):8.

Lima-Ojeda, J. M., Rupprecht, R., & Baghai, T. C. (2017). “I am i and my bacterial circumstances”: Linking gut microbiome, neurodevelopment, and depression. Frontiers in Psychiatry, 8(AUG), 1–13. http://doi.org/10.3389/fpsyt.2017.00153

Lloyd-Price, J., Abu-Ali, G., & Huttenhower, C. (2016). The healthy human microbiome. Genome Medicine, 8(1), 51. http://doi.org/10.1186/s13073-016-0307-y

Luke K Ursell, Jessica L Metcalf, Laura Wegener Parfrey, and R. K. (2013). Definig the Human Microbiome. NIH Manuscripts, 70(Suppl 1), 1–12. http://doi.org/10.1111/j.1753-4887.2012.00493.x.Defining

Manuscript, A., & Wounds, C. (2012). Current Topics in Innate Immunity II, 946, 55–68. http://doi.org/10.1007/978-1-4614-0106-3

Martín, R., Miquel, S., Langella, P., & Bermúdez-Humarán, L. G. (2014). The role of metagenomics in understanding the human microbiome in health and disease. Virulence, 5(3), 413–423. http://doi.org/10.4161/viru.27864

Mcmahon, T., Zijl, P. C. M. Van, & Gilad, A. A. (2015). NIH Public Access, 27(3), 320–331. http://doi.org/10.1002/nbm.3066.Non-invasive

Muszer, M., Noszczyńska, M., Kasperkiewicz, K., & Skurnik, M. (2015). Human Microbiome: When a Friend Becomes an Enemy. Archivum Immunologiae et Therapiae Experimentalis, 63(4), 287–298. http://doi.org/10.1007/s00005-015-0332-3

Nih, T., & Working, H. M. P. (2009). The NIH Human Microbiome Project. Genome Research, 19(12), 2317–2323. http://doi.org/10.1101/gr.096651.109.

Riiser, A. (2015). The human microbiome, asthma, and allergy. Allergy, Asthma & Clinical Immunology, 11(1), 35. http://doi.org/10.1186/s13223-015-0102-0

Roach, D. R., & Debarbieux, L. (2017). Phage therapy: awakening a sleeping giant. Emerging Topics in Life Sciences, 1(1), 93–103. http://doi.org/10.1042/ETLS20170002

Rodríguez-Rubio, L., Chang, W. L., Gutiérrez, D., Lavigne, R., Martínez, B., Rodríguez, A., … García, P. (2016). “Artilysation” of endolysin λSa2lys strongly improves its enzymatic and antibacterial activity against streptococci. Scientific Reports, 6(June), 1–11. https://doi.org/10.1038/srep35382

Sender, R., Fuchs, S., & Milo, R. (2016). Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLoS Biology, 14(8), 1–14. http://doi.org/10.1371/journal.pbio.1002533

Schmelcher, M., Donovan, D. M., & Loessner, M. J. (2012). Bacteriophage endolysins as novel antimicrobials. Future Microbiology, 7(10), 1147–1171. https://doi.org/10.2217/fmb.12.97

Schmelcher, M., & Loessner, M. J. (2016). Bacteriophage endolysins: Applications for food safety. Current Opinion in Biotechnology, 37(July), 76–87. https://doi.org/10.1016/j.copbio.2015.10.005

Smith, K. F., Goldberg, M., Rosenthal, S., Carlson, L., Chen, J., Chen, C., & Ramachandran, S. (2014). Global rise in human infectious disease outbreaks. Journal of The Royal Society Interface, 11(101), 20140950–20140950. http://doi.org/10.1098/rsif.2014.0950

Steenbergen, J. N., Alder, J., Thorne, G. M., & Tally, F. P. (2005). Daptomycin: A lipopeptide antibiotic for the treatment of serious Gram-positive infections. Journal of Antimicrobial Chemotherapy, 55(3), 283–288. http://doi.org/10.1093/jac/dkh546

Struzycka, I. (2014). The oral microbiome in dental caries. Polish Journal of Microbiology, 63(2), 127–135.

Thomas, F., Hehemann, J. H., Rebuffet, E., Czjzek, M., & Michel, G. (2011). Environmental and gut Bacteroidetes: The food connection. Frontiers in Microbiology, 2(MAY), 1–16. http://doi.org/10.3389/fmicb.2011.00093

Zaura, E., Nicu, E. A., Krom, B. P., & Keijser, B. J. F. (2014). Acquiring and maintaining a normal oral microbiome: current perspective. Frontiers in Cellular and Infection Microbiology, 4(June), 1–8. http://doi.org/10.3389/fcimb.2014.00085

http://www.bbc.com/news/health-30416844

Hojsak, I. (2017). Probiotics in Children: What Is the Evidence? Pediatric Gastroenterology, Hepatology & Nutrition,20(3), 139. https://doi.org/10.5223/pghn.2017.20.3.139

Cerdó, T., Ruíz, A., Suárez, A., & Campoy, C. (2017). Probiotic, prebiotic, and brain development. Nutrients,9(11), 1–19. https://doi.org/10.3390/nu9111247

He, M., & Shi, B. (2017). Gut microbiota as a potential target of metabolic syndrome: The role of probiotics and prebiotics. Cell and Bioscience, 7(1), 1–14. https://doi.org/10.1186/s13578-017-0183-1

Holder, M. K., & Chassaing, B. (2018). Impact of food additives on the gut-brain axis. Physiology and Behavior, (February), 0–1. https://doi.org/10.1016/j.physbeh.2018.02.025

Katan, M. B. (2012). Why the European food safety Authority was right to reject health claims for probiotics. Beneficial Microbes, 3(2), 85–89. https://doi.org/10.3920/BM2012.0008

Lebeer, S., Bron, P. A., Marco, M. L., Van Pijkeren, J. P., O’Connell Motherway, M., Hill, C., … Klaenhammer, T. (2018). Identification of probiotic effector molecules: present state and future perspectives. Current Opinion in Biotechnology, 49(November 2017), 217–223. https://doi.org/10.1016/j.copbio.2017.10.007

Ouwehand, A. C. (2017). A review of dose-responses of probiotics in human studies. Beneficial Microbes, 8(2), 143–151. https://doi.org/10.3920/BM2016.0140

Sanders, M. E., Benson, A., Lebeer, S., Merenstein, D. J., & Klaenhammer, T. R. (2018). Shared mechanisms among probiotic taxa: implications for general probiotic claims. Current Opinion in Biotechnology, 49(Figure 1), 207–216. https://doi.org/10.1016/j.copbio.2017.09.007

Shortt, C., Hasselwander, O., Meynier, A., Nauta, A., Fernández, E. N., Putz, P., … Antoine, J. M. (2018). Systematic review of the effects of the intestinal microbiota on selected nutrients and non-nutrients. European Journal of Nutrition, 57(1), 25–49. https://doi.org/10.1007/s00394-017-1546-4

Summer, A., Formaggioni, P., Franceschi, P., Frangia, F. Di, Righi, F., & Malacarne, M. (2017). Cheese as functional food: The example of parmigiano reggiano and grana padano. Food Technology and Biotechnology, 55(3), 277–289. https://doi.org/10.17113/ft b.55.03.17.5233

Thomas, F., Hehemann, J. H., Rebuffet, E., Czjzek, M., & Michel, G. (2011). Environmental and gut Bacteroidetes: The food connection. Frontiers in Microbiology, 2(MAY), 1–16. https://doi.org/10.3389/fmicb.2011.00093

Tytgat, H. L. P., Reunanen, J., Rasinkangas, P., Hendrickx, A. P. A., Laine, P. K., Paulin, L., …Vos, W. M. De. (2016). Lactobacillus rhamnosus, 82(19), 5756–5762. https://doi.org/10.1128/AEM.01243-16.Editor

Zinöcker, M. K., & Lindseth, I. A. (2018). The western diet–microbiome-host interaction and its role in metabolic disease. Nutrients, 10(3), 1–15. https://doi.org/10.3390/nu10030365]

Copyright 2018 MyMicrobiome Anstalt - All rights reserved.

DISCLAIMER: Nothing on this site or blog is intended to provide medical advice, diagnosis or treatment.

MyMicrobiome uses cookies to provide the best possible functionality. More info …
Got it!